Skip to main content
TipRanks
Go Ultimate75% OFF

Mentari Therapeutics (MWG0) Financial Statements

1 Followers

Mentari Therapeutics Financial Overview

Mentari Therapeutics's market cap is currently C$6.04M. The company's EPS TTM is C$-31.11; its P/E ratio is -0.50; Mentari Therapeutics has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Jun 26Jun 25Jun 24Jun 23Jun 22
Income Statement
Total RevenueC$ 3.18BC$ 4.94MC$ 4.60MC$ 4.14MC$ 1.09M
Gross ProfitC$ 709.84MC$ 1.71MC$ 1.10MC$ 1.40MC$ 543.55K
Operating IncomeC$ -9.90MC$ -7.92MC$ -8.13MC$ -8.38MC$ -13.79M
EBITDAC$ -9.19MC$ -7.26MC$ -7.06MC$ -7.34MC$ -18.09M
Net IncomeC$ -12.56MC$ -8.16MC$ -7.68MC$ -7.95MC$ -18.60M
Balance Sheet
Cash & Short-Term InvestmentsC$ 2.23MC$ 11.08MC$ 6.57MC$ 8.91MC$ 6.22M
Total AssetsC$ 3.03MC$ 15.58MC$ 11.82MC$ 14.11MC$ 12.79M
Total DebtC$ 0.00C$ 741.00KC$ 963.00KC$ 392.00KC$ 794.00K
Net DebtC$ -2.19MC$ -10.34MC$ -5.61MC$ -8.52MC$ -5.38M
Total LiabilitiesC$ 1.96MC$ 2.15MC$ 2.62MC$ 2.02MC$ 3.71M
Stockholders' EquityC$ 1.08MC$ 13.43MC$ 9.21MC$ 12.09MC$ 9.08M
Cash Flow
Free Cash FlowC$ -8.64MC$ -7.77MC$ -7.00MC$ -7.45MC$ -15.62M
Operating Cash FlowC$ -8.64MC$ -7.77MC$ -6.99MC$ -7.28MC$ -15.58M
Investing Cash FlowC$ 0.00C$ 0.00C$ -9.29KC$ -661.80KC$ -673.00K
Financing Cash FlowC$ 94.50KC$ 12.27MC$ 4.65MC$ 10.68MC$ 15.07M

Currency in CAD

Mentari Therapeutics Earnings and Revenue History

-2B02B4B-1800 %-1200 %-600 %0 %EarningsProfit Margin2017201820192020202120222023202420252026RevenueEarningsProfit Margin

Mentari Therapeutics Liabilities to Assets

08M16M24M0 %25 %50 %75 %LiabilitiesLiabilities to Assets2017201820192020202120222023202420252026AssetsLiabilitiesLiabilities to Assets

Mentari Therapeutics Cash Flow

-20M-10M010M20M30M2017201820192020202120222023202420252026OperatingInvestingFinancing

Mentari Therapeutics Forecast EPS vs Actual EPS

-1.5-1.2-1-0.7-0.5-0.2Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27EPS EstimateBeatMiss